Hi Guest Login
Home > Oncotype Dx Colon Cancer Test > Faridabad > Sector 12
The Oncotype DX Colon Cancer Test in Sector 12, Faridabad, offered by MAX@Home, is an advanced genomic test that assesses the risk of colon cancer recurrence and supports personalised treatment decisions. Designed for early-stage colon cancer patients, this test provides insights beyond traditional pathology reports, helping doctors decide if chemotherapy is necessary.
With seamless coordination, expert guidance, and secure sample handling, MAX@Home ensures a hassle-free and reliable testing experience at every step.
The Oncotype DX Colon Cancer Test is a genomic test that evaluates the activity of specific genes in a tumour sample collected during surgery or biopsy. Unlike routine tests, it provides a Recurrence Score that predicts how likely the cancer is to return after surgery.
This information helps oncologists personalise treatment—especially in deciding whether adding chemotherapy will provide meaningful benefit or can be safely avoided.
This test plays a crucial role in modern cancer care by enabling precision medicine. It helps:
Goes beyond standard reports by analysing gene activity, helping doctors determine how aggressive the cancer is and how it is likely to behave over time.
Provides a clear Recurrence Score that predicts the likelihood of cancer returning, enabling better planning for post-surgery care.
Identifies patients who may not benefit significantly from chemotherapy, helping them avoid potential side effects like fatigue, nausea, and lowered immunity.
Combines genomic data with clinical factors to guide treatment choices that are tailored specifically to the patient’s condition.
Reduces uncertainty by offering scientifically backed insights, allowing both patients and oncologists to make more informed and confident decisions.
The Oncotype DX Colon Cancer Test is useful for patients where treatment decisions, especially about chemotherapy, are not straightforward. It provides deeper insights into tumor biology, helping patients and doctors make more confident, personalised choices.
The test is generally recommended for:
Individuals with early-stage colon cancer often face uncertainty about recurrence risk. This test helps assess that risk more precisely, beyond standard clinical and pathology reports.
The test is performed on tumor tissue already collected during surgery or biopsy. It is most relevant after the tumor has been removed, and the next step in treatment planning is being decided.
In many cases, it’s unclear whether chemotherapy will provide significant benefit. The Oncotype DX test helps identify patients more likely to benefit from chemotherapy and those who may safely avoid it.
Patients who want a tailored approach to their cancer care can benefit from this genomic test, as it provides insights specific to their tumor’s genetic profile.
If your oncologist recommends genomic testing as part of your treatment planning, the Oncotype DX Colon Cancer Test is a clinically validated option widely used in oncology practice.
Important Note:
Not all colon cancer patients require this test. Its suitability depends on individual clinical factors such as cancer stage, pathology findings, and overall health—so always consult your oncologist before proceeding.
Your oncologist carefully reviews your diagnosis, stage of cancer, and overall health to determine if the Oncotype DX test is suitable for you.
Previously collected tumour tissue (FFPE block) from your surgery or biopsy is identified and retrieved from the hospital or pathology lab.
MAX@Home handles complete coordination, including documentation, safe packaging, and transportation of the sample to a certified genomic laboratory.
The laboratory analyses specific gene activity within the tumour and generates a detailed Recurrence Score report that predicts the risk of cancer recurrence.
Your oncologist explains the results and uses them, along with your clinical profile, to recommend the most effective and personalised treatment plan.
|
Recurrence Score |
Risk Level |
What It Indicates |
|
Low Score |
Low Risk |
Lower chance of recurrence; chemotherapy may not be required |
|
Intermediate Score |
Moderate Risk |
Treatment depends on clinical factors and the doctor’s evaluation |
|
High Score |
High Risk |
Higher recurrence risk; chemotherapy is usually recommended |
Note: Always consult your oncologist for accurate interpretation based on your overall medical condition.
Choosing the Oncotype DX Colon Cancer Test in Sector 12, Faridabad through MAX@Home ensures advanced genomic insights and a smooth, patient-friendly experience backed by clinical expertise and reliable coordination.
Our experienced healthcare professionals work closely with oncologists to ensure the test is recommended appropriately and executed with precision. From verifying eligibility to coordinating with pathology labs, every step is guided by clinical expertise, helping you get accurate results that support treatment decisions.
MAX@Home manages the complete process on your behalf, from retrieving the tumor sample from the hospital to shipping it to a certified genomic lab and delivering the final report. This eliminates the need for multiple hospital visits, reduces waiting time, and makes the experience hassle-free for patients and families.
We follow strict medical protocols for handling and transporting your tissue samples to maintain their integrity. All patient information and reports are managed with high standards of data privacy and confidentiality, ensuring safety throughout the process.
With MAX@Home, you receive clear communication at every stage, from test recommendation and documentation to timelines and pricing. There are no hidden steps or surprises, allowing you to stay informed, confident, and in control of your care journey.
Choosing the right healthcare partner for genomic testing is crucial, as it directly impacts the accuracy, coordination, and overall experience of your cancer care journey. MAX@Home ensures that every step, from sample handling to final report delivery, is managed with precision, care, and clinical expertise.
MAX@Home is backed by a well-established healthcare ecosystem with access to experienced oncologists and clinical experts. This ensures that your test is recommended appropriately, processed correctly, and interpreted in line with the latest cancer care protocols.
We take responsibility for coordinating with hospitals to retrieve your tumor sample, managing documentation, and ensuring safe shipment to certified genomic labs. This eliminates the stress of running between multiple providers and avoids unnecessary delays.
Timely results are critical in cancer treatment decisions. MAX@Home ensures efficient processing and logistics so you receive your Oncotype DX test report within the expected timeframe, without compromising accuracy or quality.
Our care team provides end-to-end support, from explaining the test and eligibility to guiding you through reports and next steps. You’ll have a single point of contact for all queries, making the process smooth and reassuring.
We work closely with your treating doctor to ensure the test results are integrated into your overall treatment strategy. This collaborative approach helps make informed, personalised decisions, especially when evaluating the need for chemotherapy.
Get accurate insights into your cancer risk and make informed treatment decisions with expert guidance from MAX@Home. Our team ensures smooth coordination, safe sample handling, and support throughout your journey.
Book your Oncotype DX Colon Cancer Test today and move forward with clarity and confidence in your treatment plan.
Read More